MiR-150, which also showed downregulated expression in patients with ASO, has been reported to negatively regulate the function of CD4+ T cells through the AKT3/Bim signaling pathway in acute graft-versus-host disease [37]. This evidence concerns the gene CD4 and acute graft versus host disease.